Kenneth Hoberman's Net Worth
Estimate Recalculated Nov 11, 2024 01:52PM EST
Who is Kenneth Hoberman
Kenneth Hoberman has an estimated net worth of $12.2 Million. This is based on reported shares across multiple companies, which include Nuvectis Pharma, Inc., TG THERAPEUTICS, INC., and STEMLINE THERAPEUTICS INC.
SEC CIK
Kenneth Hoberman's CIK is 0001573722
Past Insider Trading and Trends
2016 was Kenneth Hoberman's most active year for acquiring shares with 5 total transactions. Kenneth Hoberman's most active month to acquire stocks was the month of May. 2019 was Kenneth Hoberman's most active year for disposing of shares, totalling 13 transactions. Kenneth Hoberman's most active month to dispose stocks was the month of February. 2015 saw Kenneth Hoberman paying a total of $110,859.45 for 125,352 shares, this is the most they've acquired in one year. In 2019 Kenneth Hoberman cashed out on 172,425 shares for a total of $2,168,902.40, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
